Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
Open accessThe DOI matches its Crossref record; 143 of the 144 references it cites were found in a registry or an index.
Abstract
Bipolar disorder (BD) is strongly associated with immune dysfunction. Replicated epidemiological studies have demonstrated that BD has high rates of inflammatory medical comorbidities, including autoimmune disorders, chronic infections, cardiovascular disease and metabolic disorders. Cytokine studies have demonstrated that BD is associated with chronic low-grade inflammation with further increases in pro-inflammatory cytokine levels during mood episodes. Several mechanisms have been identified to explain the bidirectional relationship between BD and immune dysfunction. Key mechanisms include cytokine-induced monoamine changes, increased oxidative stress, pathological microglial over-activation, hypothalamic-pituitary-adrenal (HPA) axis over-activation, alterations of the microbiome-gut-brain axis and sleep-related immune changes. The inflammatory-mood pathway presents several potential novel targets in the treatment of BD. Several proof-of-concept clinical trials have shown a positive effect of anti-inflammatory agents in the treatment of BD; however, further research is needed to determine the clinical utility of these treatments. Immune dysfunction is likely to only play a role in a subset of BD patients and as such, future clinical trials should also strive to identify which specific group(s) of BD patients may benefit from anti-inflammatory treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence of altered inflammation-related markers across psychiatric conditions [6–8], along with reports of anti-inflammatory effects from psychotropic medications [9, 10] and the ameliorative impact of anti-inflammatory drugs on psychiatric symptoms [11–14], suggests a strong link between abnormal inflammatory responses and major psychiatric disorders.”
From Inflammatory ratios as predictors of length of hospitalization in psychiatric patients: A multicenter study (2025) · doi:10.1007/s00406-025-02033-9 · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“growing and converging evidence has demonstrated that immune dysfunction is involved in the pathophysiology of BD (1).”
From Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“On one hand, drugs that target IRFs have been proposed for treating psychiatric disorders, including major depression (MDD)10–12, schizophrenia (SCZ)13 and bipolar disorder (BD)14, particularly in a subset of patients with chronic inflammation10”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“The inflammatory response to infections is an essential physiological response that has been evolutionarily conserved amongst all mammal species [11]; however, in the case of chronic infections, the prolonged inflammatory response may also have deleterious effects, as the immune response is best suited for clearing an…”
BackgroundMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“, the brain) has been increasingly recognized as important [8,9].”
BackgroundThe Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
Dynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · cited 1×
“The lypolytic rate is therefore increased leading to increased production of leptin (pro-inflammatory) and decreased production of adiponectin (anti-inflammatory), thereby signaling the release of pro-inflammatory cytokines [40].”
BackgroundIrwin, M. R., Olmstead, R., & Carroll, J. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.014 · Cited by 2,085 · cited 1×
“Replicated evidence has demonstrated sleep dysfunction to be associated with increased levels of pro-inflammatory cytokines with a bidirectional causal association identified [106,107].”
BackgroundGoldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · cited 1×
“The most robust evidence exists for an association between pro-inflammatory cytokines and depressive episodes, in both bipolar and unipolar depression [50].”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 12×
“When an inflammatory comorbidity is present, peripherally released pro-inflammatory cytokines may increase systemic cytokine levels (e.g., IL-2, IL-6, TNF-α) throughout the body, Figure 1.”
BackgroundInfluentialBerk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Setiawan, E., Wilson, A. A., Mizrahi, R., Rusjan, P. M., Miler, L., Rajkowska, G., Suridjan, I., Kennedy, J. L., Rekkas, P. V., Houle, S., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2427 · Cited by 939
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Neopterin as a Marker for Immune System Activation
Murr, C., Widner, B., Wirleitner, B., & Fuchs, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605082 · Cited by 738
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609
Self-citationSleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation
Harvey, A. G. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010098 · Cited by 601
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Linking oxidative stress to inflammation: Toll-like receptors
Gill, R., Tsung, A., & Billiar, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.006 · Cited by 553
The blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · cited 3×
“Central to the inflammatory-mood pathway is the ability of peripherally circulating cytokines to traverse the blood-brain-barrier (BBB).”
BackgroundBerk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
Lopez-Munoz, F., & Alamo, C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168001 · Cited by 476
Sutterland, A. L., Fond, G., Kuin, A., Koeter, M. W. J., Lutter, R., van Gool, T., Yolken, R., Szoke, A., Leboyer, M., & de Haan, L. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12423 · Cited by 429
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Obesity, Inflammation, and Cardiovascular Risk
Mathieu, P., Lemieux, I., & Després, J.-P. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.311 · Cited by 419
Oxidative & nitrosative stress in depression: Why so much stress?
Moylan, S., Berk, M., Dean, O. M., Samuni, Y., Williams, L. J., O’Neil, A., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., et al. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.007 · Cited by 403
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
The HPA axis in bipolar disorder: Systematic review and meta-analysis
Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., Masotti, M., Respino, M., Antonioli, M., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.014 · Cited by 391
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Capuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., Layé, S., & Fuchs, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.006 · Cited by 368 · cited 1×
“With decreased BH4 levels, the activity of PH, TH and TPH is decreased thus lowering the production of dopamine, norepinephrine and serotonin [55,66,67].”
BackgroundKishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016) · Psychological Medicine · doi:10.1017/s0033291716000064 · Cited by 359 · cited 1×
“potent antidepressant effects of ketamine, an N-methyl-D-aspartate (NMDA) glutamate receptor antagonist [68,69].”
BackgroundViruses, schizophrenia, and bipolar disorder
Yolken, R. H., & Torrey, E. F. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.1.131 · Cited by 356
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339 · cited 1×
“Additionally, chronic hypercortisolemia leads to downregulation of glucocorticoid receptor synthesis, translocation and sensitivity in the pituitary and hypothalamus, effectively inhibiting the negative feedback loop of the HPA axis [94].”
BackgroundMansur, R. B., Brietzke, E., & McIntyre, R. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.017 · Cited by 322
Self-citationEndotoxin and the hypothalamo-pituitary-adrenal (HPA) axis
Beishuizen, A., & Thijs, L. G. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103125001298 · Cited by 315
Frangou, S., Lewis, M., & McCrone, P. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.1.46 · Cited by 309
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus
Bachen, E. A., Chesney, M. A., & Criswell, L. A. (2009) · Arthritis Care & Research · doi:10.1002/art.24519 · Cited by 306
Microglial Dysregulation in Psychiatric Disease
Frick, L. R., Williams, K., & Pittenger, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/608654 · Cited by 299
Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293
Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies
Palta, P., Samuel, L. J., Miller, E. R., & Szanton, S. L. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000009 · Cited by 277
Yuan, H., Yu, C., Li, X., Sun, L., Zhu, X., Zhao, C., Zhang, Z., & Yang, Z. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2527 · Cited by 266
Rapaport, M. H., Nierenberg, A. A., Schettler, P. J., Kinkead, B., Cardoos, A., Walker, R., & Mischoulon, D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.22 · Cited by 265
Autoimmune diseases, bipolar disorder, and non-affective psychosis
Eaton, W. W., Pedersen, M. G., Nielsen, P. R., & Mortensen, P. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00853.x · Cited by 262
Chapter 35 Serotonin brain circuits involved in major depression and suicide
Arango, V., Underwood, M. D., & Mann, J. J. (2002) · Progress in Brain Research · doi:10.1016/s0079-6123(02)36037-0 · Cited by 261
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · cited 2×
“Significant heterogeneity in BD cytokine studies has been problematic and, as such, there has been no clear cytokine profile that is reproducibly associated with each mood state [3,4].”
BackgroundMicroglia in the developing brain: a potential target with lifetime effects
Harry, G. J., & Kraft, A. D. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.012 · Cited by 250 · cited 1×
“Under physiological conditions, microglia may effectively prioritize the most important neural circuits leading to optimal brain structure and function [77,78].”
BackgroundHaroon, E., Fleischer, C. C., Felger, J. C., Chen, X., Woolwine, B. J., Patel, T., Hu, X. P., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.206 · Cited by 250
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure
Kupka, R. W., Nolen, W. A., Post, R. M., McElroy, S. L., Altshuler, L. L., Denicoff, K. D., Frye, M. A., Keck, P. E., Leverich, G. S., Rush, A. J., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01217-3 · Cited by 248
Pearson Murphy, B. E. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90312-s · Cited by 244
Microbiome, inflammation, epigenetic alterations, and mental diseases
Alam, R., Abdolmaleky, H. M., & Zhou, J. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32567 · Cited by 240 · cited 1×
“Numerous investigators are questioning the potential impact of altering the gut microbiota on immune function and mental illness [103].”
BackgroundThe role of ketamine in treatment-resistant depression: A systematic review
Serafini, G., Howland, R., Rovedi, F., Girardi, P., & Amore, M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140619204251 · Cited by 234 · cited 1×
“potent antidepressant effects of ketamine, an N-methyl-D-aspartate (NMDA) glutamate receptor antagonist [68,69].”
BackgroundKeck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Suppes, T., Frye, M. A., Altshuler, L. L., Kupka, R., Nolen, W. A., Leverich, G. S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.056 · Cited by 234
Effects of Lithium on Inflammation
Nassar, A., & Azab, A. N. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500038f · Cited by 219
Jiménez-Fernández, S., Gurpegui, M., Díaz-Atienza, F., Pérez-Costillas, L., Gerstenberg, M., & Correll, C. U. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09179 · Cited by 217
Microglial Activation – Tuning and Pruning Adult Neurogenesis
Ekdahl, C. T. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00041 · Cited by 212
Miyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.002 · Cited by 212
Neuroinflammation in bipolar disorder – A [11C]-(R)-PK11195 positron emission tomography study
Haarman, B. C. M. (., Riemersma-Van der Lek, R. F., de Groot, J. C., Ruhé, H. G. (., Klein, H. C., Zandstra, T. E., Burger, H., Schoevers, R. A., de Vries, E. F. J., Drexhage, H. A., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.03.016 · Cited by 211
Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications
Mcintyre, R., Konarski, J., Misener, V., & Kennedy, S. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230590932380 · Cited by 203
Self-citationYang, J.-J., Wang, N., Yang, C., Shi, J.-Y., Yu, H.-Y., & Hashimoto, K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.021 · Cited by 202
Causes of decreased life expectancy over the life span in bipolar disorder
Kessing, L. V., Vradi, E., McIntyre, R. S., & Andersen, P. K. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.027 · Cited by 200
Self-citationRosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199 · cited 2×
“002), indicative of a moderate antidepressant effect with good overall tolerability [113].”
BackgroundSelf-citationEdwards, L. J., & Constantinescu, C. S. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1087oa · Cited by 193
Not fade away: the HPA axis and depression
Cowen, P. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709005558 · Cited by 191 · cited 1×
“Further, impaired cortisol suppression itself has long been recognized a strong predictor of mood disorders [98].”
BackgroundNovel therapeutic targets in depression: Minocycline as a candidate treatment
Soczynska, J. K., Mansur, R. B., Brietzke, E., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 189
Self-citationBipolar Disorder and Inflammation
Rosenblat, J. D., & McIntyre, R. S. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.09.006 · Cited by 186
Self-citationLongevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine
Unger, R. H. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.014 · Cited by 184 · cited 1×
“, greater caloric intake then expenditure), adipocytes undergo hypertrophy and have increased triglyceride stores [39].”
BackgroundTreatment-resistant bipolar disorder
Gitlin, M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001793 · Cited by 184
Is bipolar disorder an inflammatory condition? The relevance of microglial activation
Stertz, L., Magalhães, P. V. S., & Kapczinski, F. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835aa4b4 · Cited by 183
Rizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183
Self-citationBerk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.005 · Cited by 181 · cited 1×
“An eight-week open-label trial of NAC also showed antidepressant effects in BD [117].”
BackgroundMedical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems
SayuriYamagata, A., Brietzke, E. M., Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.059 · Cited by 175
Self-citationVisceral obesity and the heart
Mathieu, P., Pibarot, P., Larose, É., Poirier, P., Marette, A., & Després, J.-P. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.001 · Cited by 174
Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172 · cited 1×
“gondii, CMV and HSV1 have been associated with poorer cognitive function in BD [22,23].”
BackgroundSelf-citationThe role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
Maurya, P. K., Noto, C., Rizzo, L. B., Rios, A. C., Nunes, S. O. V., Barbosa, D. S., Sethi, S., Zeni, M., Mansur, R. B., Maes, M., et al. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.016 · Cited by 171
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S., Alsuwaidan, M., Yim, C. Y., & McIntyre, R. S. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 164
Self-citationOxidative/nitrosative stress and antidepressants: Targets for novel antidepressants
Lee, S., Lee, S.-J., Han, C., Patkar, A. A., Masand, P. S., & Pae, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.008 · Cited by 163
Can body mass index help predict outcome in patients with bipolar disorder?
Calkin, C., Van De Velde, C., Růžičková, M., Slaney, C., Garnham, J., Hajek, T., O’Donovan, C., & Alda, M. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00730.x · Cited by 158
Haroon, E., Woolwine, B. J., Chen, X., Pace, T. W., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.25 · Cited by 154
Haroon, E., & Miller, A. H. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_40 · Cited by 153
Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism
Wang, J., & Dunn, A. J. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00016-3 · Cited by 151
Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression
Barbosa, I. G., Bauer, M. E., Machado-Vieira, R., & Teixeira, A. L. (2014) · Neural Plasticity · doi:10.1155/2014/360481 · Cited by 147
Hypothalamic-Pituitary-Adrenal Axis Dysfunction and Illness Progression in Bipolar Disorder
Fries, G. R., Vasconcelos-Moreno, M. P., Gubert, C., Santos, B. T. M. Q. D., Sartori, J., Eisele, B., Ferrari, P., Fijtman, A., Ruegg, J., Gassen, N. C., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu043 · Cited by 147
Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145
Husain, M. I., Chaudhry, I. B., Husain, N., Khoso, A. B., Rahman, R. R., Hamirani, M. M., Hodsoll, J., Qurashi, I., Deakin, J. F., & Young, A. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117724352 · Cited by 144
Neuroinflammatory basis of metabolic syndrome
Purkayastha, S., & Cai, D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.005 · Cited by 144
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 143
The Immunology of Bipolar Disorder
Barbosa, I. G., Machado-Vieira, R., Soares, J. C., & Teixeira, A. L. (2014) · Neuroimmunomodulation · doi:10.1159/000356539 · Cited by 138
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
Dantzer, R., & Walker, A. K. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1187-1 · Cited by 136
Bested, A. C., Logan, A. C., & Selhub, E. M. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-5 · Cited by 132
Mood disorders: cardiovascular and diabetes comorbidity
Fenton, W. S., & Stover, E. S. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000228765.33356.9f · Cited by 128
Mapping inflammation onto mood: inflammatory mediators of anhedonia
Swardfager, W., Rosenblat, J. D., Benlamri, M., & McIntyre, R. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.017 · Cited by 125
Self-citationMaes, M., Ringel, K., Kubera, M., Berk, M., & Rybakowski, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.016 · Cited by 116
N-acetylcysteine for major depressive episodes in bipolar disorder
Magalhães, P. V., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2011) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462011000400011 · Cited by 114
Omega-3 Fatty Acid Treatment and T2 Whole Brain Relaxation Times in Bipolar Disorder
Hirashima, F., Parow, A. M., Stoll, A. L., Demopulos, C. M., Damico, K. E., Rohan, M. L., Eskesen, J. G., Zuo, C. S., Cohen, B. M., & Renshaw, P. F. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1922 · Cited by 111
Perugi, G., Quaranta, G., Belletti, S., Casalini, F., Mosti, N., Toni, C., & Dell’Osso, L. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.052 · Cited by 111
Malaise, melancholia and madness: The evolutionary legacy of an inflammatory bias
Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.009 · Cited by 110
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
McNamara, R. K., & Lotrich, F. E. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.98 · Cited by 108
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
Dean, O. M., Kanchanatawan, B., Ashton, M., Mohebbi, M., Ng, C. H., Maes, M., Berk, L., Sughondhabirom, A., Tangwongchai, S., Singh, A. B., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417709357 · Cited by 105
The role of adipokines in the rapid antidepressant effects of ketamine
Machado-Vieira, R., Gold, P. W., Luckenbaugh, D. A., Ballard, E. D., Richards, E. M., Henter, I. D., De Sousa, R. T., Niciu, M. J., Yuan, P., & Zarate, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.36 · Cited by 102 · cited 1×
“In addition, an antidepressant response to ketamine may be predicted by elevated baseline inflammatory markers [74,75], further suggestive of significant cross-talk between immune dysfunction, the glutamate system and mood disorder pathophysiology.”
BackgroundMetabolic Syndrome in Bipolar Disorder: A Review With a Focus on Bipolar Depression
McElroy, S. L., & Keck, P. E. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08634 · Cited by 99
Arabzadeh, S., Ameli, N., Zeinoddini, A., Rezaei, F., Farokhnia, M., Mohammadinejad, P., Ghaleiha, A., & Akhondzadeh, S. (2015) · Bipolar Disorders · doi:10.1111/bdi.12324 · Cited by 98
Frangou, S., Lewis, M., Wollard, J., & Simmons, A. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106067787 · Cited by 98
Are medical comorbid conditions of bipolar disorder due to immune dysfunction?
Rosenblat, J. D., & McIntyre, R. S. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12414 · Cited by 97
Self-citationBerk, M., Dean, O. M., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B., Kohlmann, K., Jeavons, S., Hewitt, K., Moss, K., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-91 · Cited by 96
Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis
Bartoli, F., Crocamo, C., Mazza, M. G., Clerici, M., & Carrà, G. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.007 · Cited by 96
The microbiota–gut–brain axis: learning from intestinal bacteria?
Bercik, P. (2011) · Gut · doi:10.1136/gut.2010.226779 · Cited by 87
Update on Biology: Uric Acid and the Activation of Immune and Inflammatory Cells
Martinon, F. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-010-0092-3 · Cited by 77
Emadi-Kouchak, H., Mohammadinejad, P., Asadollahi-Amin, A., Rasoulinejad, M., Zeinoddini, A., Yalda, A., & Akhondzadeh, S. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000098 · Cited by 75
The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review
van den Ameele, S., van Diermen, L., Staels, W., Coppens, V., Dumont, G. J. H., Sabbe, B., & Morrens, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.016 · Cited by 73
Han, C., Lofland, J. H., Zhao, N. O., & Schenkel, B. (2011) · PubMed · Cited by 73
Regulation of noradrenergic function by inflammatory cytokines and depolarization
Li, W., Knowlton, D., Woodward, W. R., & Habecker, B. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01890.x · Cited by 71
Hamdani, N., Daban, C., Lajnef, M., Gadel, R., Corvoisier, P. L., Delavest, M., Carde, S., Lépine, J., Jamain, S., Houenou, J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.038 · Cited by 67
Siwek, M., Sowa-Kućma, M., Styczeń, K., Misztak, P., Nowak, R. J., Szewczyk, B., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0124-8 · Cited by 65 · cited 1×
“Increased depression severity is associated with greater elevations of pro-inflammatory cytokines [52].”
BackgroundMousavi, S. Y., Khezri, R., Karkhaneh-Yousefi, M.-A., Mohammadinejad, P., Gholamian, F., Mohammadi, M. R., Zeinoddini, A., & Akhondzadeh, S. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0207 · Cited by 61
Saroukhani, S., Emami‐Parsa, M., Modabbernia, A., Ashrafi, M., Farokhnia, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Bipolar Disorders · doi:10.1111/bdi.12108 · Cited by 59 · cited 1×
“, assessed the effect of adjunctive aspirin in an RCT with male BD patients (n = 32) and found no significant difference between treatment groups by the primary endpoint of 6-weeks [127].”
MethodPossible antidepressant effect of minocycline
Levine, J., Cholestoy, A., & Zimmerman, J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.582b · Cited by 59
Bartoli, F., Crocamo, C., Clerici, M., & Carrà, G. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.180281 · Cited by 59
A preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania
Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58 · cited 1×
“This analysis revealed a greater improvement in symptoms of mania in the NAC group compared to placebo [118].”
ResultPhysical health of patients with bipolar disorder
Young, A. H., & Grunze, H. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12117 · Cited by 56
Strejilevich, S., Samamé, C., & Martino, D. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.018 · Cited by 55
Cardiovascular Disease and Bipolar Disorder: Risk and Clinical Implications
Swartz, H. A., & Fagiolini, A. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12ac08227 · Cited by 54
Horrobin, D. F., & Lieb, J. (1981) · Medical Hypotheses · doi:10.1016/0306-9877(81)90044-x · Cited by 53
Rheumatoid Arthritis and the Risk of Bipolar Disorder: A Nationwide Population-Based Study
Hsu, C.-C., Chen, S.-C., Liu, C.-J., Lu, T., Shen, C.-C., Hu, Y.-W., Yeh, C.-M., Chen, P.-M., Chen, T.-J., & Hu, L.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107512 · Cited by 49
Soczynska, J. K., Kennedy, S. H., Alsuwaidan, M., Mansur, R. B., Li, M., McAndrews, M. P., Brietzke, E., Woldeyohannes, H. O., Taylor, V. H., & McIntyre, R. S. (2017) · Bipolar Disorders · doi:10.1111/bdi.12496 · Cited by 49
Self-citationTotal sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder
Mukherjee, D., Krishnamurthy, V., Millett, C. E., Reider, A., Can, A., Groer, M. E., Fuchs, D., Postolache, T. T., & Saunders, E. F. H. (2017) · Bipolar Disorders · doi:10.1111/bdi.12529 · Cited by 46
Treatment-Resistant Bipolar Disorder
(2012) · Management of Treatment-Resistant Major Psychiatric Disorders · doi:10.1093/med/9780199739981.003.0004 · Cited by 46
Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Chen, P. S., Huang, S.-Y., Tzeng, N.-S., Wang, Y.-S., Wang, L.-J., Lee, I. H., Wang, T.-Y., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000109 · Cited by 45
Review of lithium effects on immune cells
Maddu, N., & Raghavendra, P. B. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.998369 · Cited by 40
Increased risk of gout among patients with bipolar disorder: A nationwide population-based study
Chung, K., Huang, C., & Lin, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.07.012 · Cited by 39
Hamdani, N., Boukouaci, W., Hallouche, M. R., Charron, D. J., Krishnamoorthy, R., Leboyer, M., & Tamouza, R. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415595873 · Cited by 33
Selfish brain and neuroprogression in bipolar disorder
Mansur, R. B., Cha, D. S., Asevedo, E. D. M., McIntyre, R. S., & Brietzke, E. M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.004 · Cited by 31
Self-citationDolsen, E. A., Soehner, A. M., & Harvey, A. G. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000529 · Cited by 29
Cardiovascular Risk Factors in Outpatients with Bipolar Disorder
Klumpers, U. M., Boom, K., Janssen, F. M., Tulen, J. H., & Loonen, A. J. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832594 · Cited by 27
Young, A. H. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000020 · Cited by 25
Kargar, M., Yoosefi, A., Akhondzadeh, S., Artonian, V., Ashouri, A., & Ghaeli, P. (2015) · Pharmacopsychiatry · doi:10.1055/s-0035-1559667 · Cited by 20
Maes, M., Bosmans, E., Scharpé, S., D'Hondt, P., & Desnyder, R. (1995) · European Psychiatry · doi:10.1016/0924-9338(96)80345-2 · Cited by 19
Sleep and Inflammation: Implications for Domain Approach and Treatment Opportunities
McIntyre, R. S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.018 · Cited by 17
Self-citation
Research works printed but not linked: 2
- Abbas, A.K., Lichtman, A.H., and Pillai, S. (2012). Cellular and Molecular Immunology, Elsevier Saunders. [7th ed.].
- Boutzios, G., and Kaltsas, G. (2017, October 29). Immune System Effects on the Endocrine System, Available online: https://www.ncbi.nlm.nih.gov/books/NBK279139/.
Cited by
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Misiak, B., Łoniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., & Samochowiec, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109951 · Cited by 343
Neuroinflammation in Bipolar Depression
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G., & Furlan, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00071 · Cited by 274
Revisiting inflammation in bipolar disorder
Fries, G. R., Walss-Bass, C., Bauer, M. E., & Teixeira, A. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.006 · Cited by 147
Ortega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Martinez-Rozas, L., Rodríguez–Jiménez, R., Álvarez‐Mon, M., & Lahera, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01964-w · Cited by 150
Metadata
- Authors
- Rosenblat, J., & McIntyre, R.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Rosenblat, Joshua
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2017-10-30
- Volume
- 7
- Issue
- 11
- Pages
- 144
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC5704151
- OpenAlex
- W2766540017
- Cited by
- 258
- References
- 144
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 34 · 2023: 35 · 2022: 42 · 2021: 38 · 2020: 31 · 2019: 26 · 2018: 10
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, immune dysfunction, inflammation, autoimmune disease comorbidity, low-grade inflammation, inflammatory cytokines, oxidative stress, microglial activation, hypothalamic-pituitary-adrenal axis, microbiome-gut-brain axis, sleep and immunity, anti-inflammatory therapy, mood episodes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.